BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18774893)

  • 1. Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Shaw LJ; Merz CN; Bittner V; Kip K; Johnson BD; Reis SE; Kelsey SF; Olson M; Mankad S; Sharaf BL; Rogers WJ; Pohost GM; Sopko G; Pepine CJ;
    J Womens Health (Larchmt); 2008 Sep; 17(7):1081-92. PubMed ID: 18774893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Linke SE; Rutledge T; Johnson BD; Vaccarino V; Bittner V; Cornell CE; Eteiba W; Sheps DS; Krantz DS; Parashar S; Bairey Merz CN
    Arch Gen Psychiatry; 2009 May; 66(5):499-507. PubMed ID: 19414709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
    Rutledge T; Linke SE; Johnson BD; Bittner V; Krantz DS; Whittaker KS; Eastwood JA; Eteiba W; Cornell CE; Pepine CJ; Vido DA; Olson MB; Shaw LJ; Vaccarino V; Bairey Merz CN
    Psychosom Med; 2010 Jul; 72(6):549-55. PubMed ID: 20410246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
    Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.
    Shaw LJ; Merz CN; Pepine CJ; Reis SE; Bittner V; Kip KE; Kelsey SF; Olson M; Johnson BD; Mankad S; Sharaf BL; Rogers WJ; Pohost GM; Sopko G;
    Circulation; 2006 Aug; 114(9):894-904. PubMed ID: 16923752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
    Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
    Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
    Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
    J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
    Arant CB; Wessel TR; Olson MB; Bairey Merz CN; Sopko G; Rogers WJ; Sharaf BL; Reis SE; Smith KM; Johnson BD; Handberg E; Mankad S; Pepine CJ;
    J Am Coll Cardiol; 2004 Jun; 43(11):2009-14. PubMed ID: 15172405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.
    Shaw LJ; Bairey Merz CN; Azziz R; Stanczyk FZ; Sopko G; Braunstein GD; Kelsey SF; Kip KE; Cooper-Dehoff RM; Johnson BD; Vaccarino V; Reis SE; Bittner V; Hodgson TK; Rogers W; Pepine CJ
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1276-84. PubMed ID: 18182456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
    Rutledge T; Kenkre TS; Bittner V; Krantz DS; Thompson DV; Linke SE; Eastwood JA; Eteiba W; Cornell CE; Vaccarino V; Pepine CJ; Johnson BD; Bairey Merz CN
    Int J Cardiol; 2013 Oct; 168(3):2335-40. PubMed ID: 23410495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
    Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
    J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study.
    Rutledge T; Vaccarino V; Johnson BD; Bittner V; Olson MB; Linke SE; Cornell CE; Eteiba W; Sheps DS; Francis J; Krantz DS; Bairey Merz CN; Parashar S; Handberg E; Vido DA; Shaw LJ
    J Am Coll Cardiol; 2009 Jan; 53(2):176-83. PubMed ID: 19130986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Shufelt C; Bretsky P; Almeida CM; Johnson BD; Shaw LJ; Azziz R; Braunstein GD; Pepine CJ; Bittner V; Vido DA; Stanczyk FZ; Bairey Merz CN
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4985-92. PubMed ID: 20739385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.
    Sedlak TL; Johnson BD; Pepine CJ; Reis SE; Bairey Merz CN
    PLoS One; 2013; 8(9):e74585. PubMed ID: 24058592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    von Mering GO; Arant CB; Wessel TR; McGorray SP; Bairey Merz CN; Sharaf BL; Smith KM; Olson MB; Johnson BD; Sopko G; Handberg E; Pepine CJ; Kerensky RA;
    Circulation; 2004 Feb; 109(6):722-5. PubMed ID: 14970106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study.
    Olson MB; Kelsey SF; Matthews KA; Bairey Merz CN; Eteiba W; McGorray SP; Cornell CE; Vido DA; Muldoon MF
    J Womens Health (Larchmt); 2008 Mar; 17(2):187-94. PubMed ID: 18321170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Rutledge T; Linke SE; Krantz DS; Johnson BD; Bittner V; Eastwood JA; Eteiba W; Pepine CJ; Vaccarino V; Francis J; Vido DA; Merz CN
    Psychosom Med; 2009 Nov; 71(9):958-64. PubMed ID: 19834049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry.
    Berman AN; Biery DW; Ginder C; Singh A; Baek J; Wadhera RK; Wu WY; Divakaran S; DeFilippis EM; Hainer J; Cannon CP; Plutzky J; Polk DM; Nasir K; Di Carli MF; Ash AS; Bhatt DL; Blankstein R
    JAMA Cardiol; 2021 Aug; 6(8):880-888. PubMed ID: 34009238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.